In this activity, expert faculty discuss recent advances in timely, biomarker-guided diagnosis and consider how current and emerging intravenous (IV) and subcutaneous (SC) disease-modifying therapies (DMTs) may impact clinical practice and enable treatment individualization based on the underlying pathology of Alzheimer s disease. This activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and touchIME in collaboration with the Gerontological Society of America (GSA).
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 12001 Sunrise Valley Dr.
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedJul 29, 2026
-
Last day to claim creditJul 30, 2027 10 months left
-
Global Learning Collaborative Reimagining Alzheimer’s Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy an Impact Live Series
-
Massachusetts Medical Society Alzheimer s Disease and Dementia Care: Diagnosis, Support, and Treatment Strategies
-
eMedEd Breakthrough Treatments in Dementing Illnesses
-
touchIME +1 Reimagining Alzheimer s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives
-
Efficient, LLC +1 Advancing Patient Care in Late-Onset Pompe Disease: Utilizing Patient Perspectives to Facilitate Timely Diagnosis and Patient-Centered Therapy
-
Efficient LLC +1 What Gets Under Patients Skin: Integrating Subcutaneous Immune Checkpoint Inhibitor Formulations into the Management of Solid Tumors in Oncology Practice
